These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 879127)

  • 61. Fibrin Ring Granulomas in Checkpoint Inhibitor-induced Hepatitis.
    Everett J; Srivastava A; Misdraji J
    Am J Surg Pathol; 2017 Jan; 41(1):134-137. PubMed ID: 27792061
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Liver damage due to drugs. I].
    Fossati C
    Clin Ter; 1974 Jan; 68(1):75-85. PubMed ID: 4595636
    [No Abstract]   [Full Text] [Related]  

  • 63. Carbimazole-induced acute cholestatic hepatitis.
    Ozenne G; Manchon ND; Doucet J; Hémet J; Schrub JC; Bercoff E
    J Clin Gastroenterol; 1989 Feb; 11(1):95-7. PubMed ID: 2646363
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Severe acute cholestatic hepatitis with prolonged cholestasis and bile-duct injury following atorvastatin therapy: a case report.
    Rahier JF; Rahier J; Leclercq I; Geubel AP
    Acta Gastroenterol Belg; 2008; 71(3):318-20. PubMed ID: 19198578
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Quinidine-induced granulomatous hepatitis.
    Chajek T; Lehrer B; Geltner D; Levij IS
    Ann Intern Med; 1974 Dec; 81(6):774-6. PubMed ID: 4433082
    [No Abstract]   [Full Text] [Related]  

  • 66. Aprindine-induced hepatic granulomata.
    Elisaf M; Stefanaki-Nikou S; Voulgarelis M; Masalas C; Tsianos EV
    J Hepatol; 1992 Mar; 14(2-3):276-9. PubMed ID: 1500691
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Development of granulomatous hepatitis during treatment with interferon-alpha 2b.
    Propst A; Propst T; Dietze O; Kathrein H; Judmeier G; Vogel W
    Dig Dis Sci; 1995 Oct; 40(10):2117-8. PubMed ID: 7587776
    [No Abstract]   [Full Text] [Related]  

  • 68. [2 cases of acute cholestasis caused by ticlopidine].
    Guzzini F; Banfi L; Gomitoni A; Marchegiani C; Novati P; Mesina M; Frigerio B
    Recenti Prog Med; 1997 Mar; 88(3):124-7. PubMed ID: 9173469
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Delayed diagnosis of cholestatic drug-induced liver injury treated with corticosteroid for adrenal insufficiency secondary to miliary tuberculosis.
    Lee SY; Schneier A; Schiano T; Liu SJ; Machado ON
    Eur Rev Med Pharmacol Sci; 2015 Aug; 19(16):3046-9. PubMed ID: 26367727
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pyrazinamide-induced granulomatous hepatitis.
    Knobel B; Buyanowsky G; Dan M; Zaidel L
    J Clin Gastroenterol; 1997 Jun; 24(4):264-6. PubMed ID: 9252856
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Phenylbutazone, oxyphenbutazone labeling revised.
    FDA Drug Bull; 1984 Dec; 14(3):23-4. PubMed ID: 6526172
    [No Abstract]   [Full Text] [Related]  

  • 72. Drug rash with eosinophilia and systemic signs syndrome in a patient with multiple sclerosis.
    Caruso A; Vecchio R; Patti F; Neri S
    Clin Ther; 2009 Mar; 31(3):580-4. PubMed ID: 19393848
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Phenprocoumon-induced cholestatic hepatitis].
    Woolley S; Burger HR; Zellweger U
    Dtsch Med Wochenschr; 1995 Nov; 120(44):1507-10. PubMed ID: 7588020
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hepatic granulomas in leprosy. Their relation to bacteremia.
    Chen TS; Drutz DJ; Whelan GE
    Arch Pathol Lab Med; 1976 Apr; 100(4):182-5. PubMed ID: 786214
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Clinical and morphological findings on 2 cases of icterus induced by butazolidines].
    Coltorti M; Cuccurullo L; Del Vecchio-Blanco C
    Policlinico Prat; 1970 Mar; 77(10):309-24. PubMed ID: 5436754
    [No Abstract]   [Full Text] [Related]  

  • 76. Acute cholestatic hepatitis after exposure to isoflurane.
    Malnick SD; Mahlab K; Borchardt J; Sokolowski N; Attali M
    Ann Pharmacother; 2002 Feb; 36(2):261-3. PubMed ID: 11847945
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Fixed drug eruption to oxyphenbutazone and phenylbutazone.
    Nayyar KC; Pasricha JS
    Dermatologica; 1972; 144(4):214-6. PubMed ID: 5076722
    [No Abstract]   [Full Text] [Related]  

  • 78. [Rules for the histological evaluation of drug-induced liver lesions].
    Bianchi L; De Groote J; Desmet V; Gedigk P; Korb G; Popper H; Poulsen H; Scheuer PJ; Schmid M; Thaler H; Wepler W
    Dtsch Med Wochenschr; 1975 Aug; 100(35):1746-50. PubMed ID: 1157673
    [No Abstract]   [Full Text] [Related]  

  • 79. Phenylbutazone, oxyphenbutazone and aplastic anaemia.
    Böttiger LE
    Br Med J; 1977 Jul; 2(6081):265. PubMed ID: 884472
    [No Abstract]   [Full Text] [Related]  

  • 80. Outcome and prognostic markers in severe drug-induced liver disease.
    Björnsson E; Olsson R
    Hepatology; 2005 Aug; 42(2):481-9. PubMed ID: 16025496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.